MENU
+Compare
STOK
Stock ticker: NASDAQ
AS OF
Oct 7, 04:59 PM (EDT)
Price
$27.31
Change
+$0.50 (+1.86%)
Capitalization
1.47B

STOK Stoke Therapeutics Forecast, Technical & Fundamental Analysis

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine... Show more

STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for STOK with price predictions
Oct 06, 2025

STOK's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for STOK turned positive on October 06, 2025. Looking at past instances where STOK's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on STOK as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STOK advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 235 cases where STOK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STOK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

STOK broke above its upper Bollinger Band on October 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STOK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.386) is normal, around the industry mean (23.464). P/E Ratio (30.816) is within average values for comparable stocks, (54.589). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.244). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (7.806) is also within normal values, averaging (345.477).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STOK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

STOK is expected to report earnings to rise 45.12% to -58 cents per share on November 11

Stoke Therapeutics STOK Stock Earnings Reports
Q3'25
Est.
$-0.58
Q2'25
Beat
by $0.10
Q1'25
Beat
by $1.82
Q4'24
Beat
by $0.37
Q3'24
Beat
by $0.07
The last earnings report on August 12 showed earnings per share of -40 cents, beating the estimate of -50 cents. With 423.50K shares outstanding, the current market capitalization sits at 1.47B.
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PYODX47.80N/A
N/A
Victory Pioneer Y
SLCGX34.59N/A
N/A
Saratoga Large Capitalization Growth I
VGREX7.16N/A
N/A
VALIC Company I Global Real Estate
PQSAX24.95N/A
N/A
Virtus KAR Small-Cap Value A
VKSRX20.64N/A
N/A
Virtus KAR Small-Mid Cap Core R6

STOK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with QTTB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+4.89%
QTTB - STOK
49%
Loosely correlated
+4.83%
DNLI - STOK
48%
Loosely correlated
-1.30%
SYRE - STOK
47%
Loosely correlated
+4.91%
IDYA - STOK
46%
Loosely correlated
-0.54%
IMNM - STOK
46%
Loosely correlated
+16.40%
More